An awareness campaign is underway to ensure people know the best place to access healthcare this winter.
Right Care Right Place helps the public decide the most appropriate service for their healthcare needs – whether they should contact their GP or pharmacy, call NHS 24 on 111 or use self-help guides on the NHS Inform website. Hospital emergency departments should only be visited for critical emergencies.
The campaign features targeted advertising on television, radio and online and aims to help alleviate pressures on the NHS and social care ahead of an expected seasonal increase in demand.
Health Secretary Neil Gray visited East Lothian Community Hospital to hear about work being undertaken to address delayed discharges. The hospital supports patients leaving acute hospitals who require intermediate care before returning home.
Mr Gray said: “We have been working closely with colleagues across the NHS and social care to make sure we are as prepared as possible ahead of winter.
“Public information and awareness of the treatment options and how to access them when needed is key to ensuring services are directed where they are most needed.
“This will help everyone to get the right care, in the right place as quickly as possible while helping alleviate pressures on the rest of the NHS. People can also help by making sure they receive their Respiratory Syncytial Virus (RSV), Covid-19 and flu vaccinations if eligible.”
Self-help guides can be found on NHS inform and include advice on the most common winter illnesses.
Medical equipment and supplies will be sent from Scotland to Ukraine.
The shipment of over 500 items includes oxygen concentrators, electric height-adjustable beds with replacement batteries and mattresses, and ICU ventilators identified by NHS Scotland as surplus to operational requirements
The donation will not impact on services to patients using the healthcare services in Scotland.
It brings the total value of medical supplies donated from Scotland to Ukraine to £3.8 million.
First Minister John Swinney confirmed the latest donation during a meeting with the Ukrainian Ambassador to the UK General Valerii Zaluzhnyi in London. It follows a request from the Ukrainian Consulate in Edinburgh in May 2024 to contribute medical equipment on a humanitarian basis.
The First Minister said: “The people of Ukraine are suffering as a consequence of the illegal invasion of their country, and it is vital we do all we can to support them.
“These supplies, identified by NHS Scotland as being surplus to requirements, will provide direct humanitarian support to Ukraine at a critical time.
“Scotland stands in solidarity with Ukraine and offers unqualified support for its independence, sovereignty and territorial integrity.”
Ambassador of Ukraine to the United Kingdom General Valerii Zaluzhnyi said: “The act of generosity and solidarity demonstrated by NHS Scotland in extending a helping hand to Ukraine in its time of need exemplifies the true spirit of humanity and compassion.
“It serves as a powerful reminder that, in the face of adversity, solidarity and cooperation can transcend borders and make a meaningful impact on the lives of those in war. The Ukrainian people are deeply grateful for the support and assistance provided by NHS Scotland, knowing that these supplies will make a difference between life and death for many.
“The bonds of friendship and solidarity forged through this act of kindness will not be forgotten and will serve as a beacon of hope for a brighter future beyond the shadows of Russia’s war against Ukraine.”
Agenda for Change pay offer accepted by trade unions
Almost 170,000 nurses and healthcare workers in Scotland will receive a 5.5% salary increase this year, ensuring they have the best reward package in the UK.
Unions representing NHS Agenda for Change staff – which includes nurses, midwives, paramedics, allied health professionals, porters and others – unanimously agreed to an investment of more than £448 million for improved pay conditions.
The pay rise, backdated to 1 April 2024, will come into effect from next month.
Health Secretary Neil Gray said: “I am pleased that trade unions have unanimously agreed to accept this pay offer, which ensures that nurses and healthcare staff in Scotland, who are part of Agenda for Change, will have the best reward package in the UK.
“I want to express my thanks again to Scotland’s hardworking healthcare staff for the care they provide to patients, day in, day out. They are the very backbone of the NHS and we are committed to ensuring they feel supported and valued.”
Children in Scotland diagnosed with a brain tumour that has a specific genetic mutation can now be treated on the NHS with a kinder, more effective targeted therapy.
It’s used in combination with another medicine, trametinib, and both can be administered at home as they are taken orally. This means fewer hospital visits.
The news follows the approval given in April this year by the National Institute for Health and Care Excellence (NICE).
Current standard treatment for the condition typically involves surgery – where that’s possible – chemotherapy and/or radiotherapy. But less than 30% of children diagnosed with high-grade gliomas survive for five years or more and the treatment often has brutal side effects.
Outcomes for low grade gliomas – the most common childhood brain tumour – are better at a 90% survival rate following surgery. But chemotherapy may also be prescribed whereas this treatment means improved quality of life for patients as clinical trials showed its side effects were rare.
The combination medication is the first targeted treatment to be made available on the NHS for paediatric gliomas. It is already licensed for use in the USA, and for use in the UK in adults with the BRAF mutation who have some types of lung and skin cancers.
The two drugs work together to block the growth signal coming from the mutant BRAF protein, slowing or even stopping the tumour from growing.
Brain tumours affect around 500 children a year in the UK, of whom between 150 to 175 may have a glioma and fewer still will have the BRAF mutation. But despite the small numbers involved, this is the first progress made in treating the disease in years.
In 2008, research carried out by Dr David Jones which was funded by The Brain Tumour Charity (then known as the Samantha Dickson Brain Tumour Trust), identified a BRAF mutation that was common in pilocytic astrocytoma brain tumours.
This was the first time that a specific genetic change had been detected in these tumour types and it paved the way for drug development as it could then become a target for diagnostic tests, changing the research landscape for low grade brain tumours in children.
Dr Jones now leads the EVEREST Centre in Germany, which carries out research into paediatric low grade brain tumours.
Dr Michele Afif, Chief Executive at The Brain Tumour Charity, said: “We are delighted that the Scottish Medicines Consortium has joined NICE in approving the first new treatment for paediatric brain tumours in decades.
“We hope that this will be the first of many new treatments that will ensure our community can live longer and better lives.”
To find out more about The Brain Tumour Charity, visit:
Curbing sky rocketing A&E waiting times must be the number one priority for the Scottish government with winter just around the corner.
That is the call from The Royal College of Emergency Medicine (RCEM) Scotland as A&E performance data for July represented the worst July since records began in 2011 for extended wait times in Emergency Departments.
This is double the number of people who waited this long in July last year.
The data also shows long waits have increased significantly since the 2010s.
Since July 2017, for example, the numbers of people waiting four hours or more has increased by nearly seven times (5553 to 38,379), eight hours or more by 53 times (248 to 13,146), and 12 hours or more by 279 times (20 to 5,593). This was despite attendances only increasing by 0.9% in the same period.
Delays in discharging patients is a key reason that doctors cannot admit patients into hospitals from their Emergency Departments, therefore causing long waits. In July, there were 61,165 days spent in hospital by people who were well enough to be discharged but unable to be due to a lack of social care provisions. This is equivalent to 167 years.
Dr John-Paul Loughrey, RCEM Vice President for Scotland said: “The Scottish government must take heed and put measures in place to end long wait times in our Emergency Departments.
“These staggering statistics are deeply worrying for the people of Scotland who are facing incredibly long and tiring waits despite it being summer. We have been dealing with ‘winter levels’ of pressure, which does not bode well as we start to head into the colder months. The first day of winter is just three months away, which will inevitably heap pressure on the health care system.
“Continuing to focus on diverting patients away from A&E rather than addressing the capacity problems will not avert the coming crisis. These statistics aren’t just numbers. They are people who have come to our Emergency Departments needing emergency care. They deserve better. Our health care colleagues deserve better.”
A graphical representation of the data can be found here.
In a ground-breaking first for Scotland, laboratory specimens have been flown from one NHS board to another – by drone.
This step forward by the Project CAELUS initiative, led by AGS Airports in partnership with NHS Scotland, took place during a three-week flight trial between NHS Lothian and NHS Borders.
Live flying took place between the Edinburgh BioQuarter next to the Royal Infirmary of Edinburgh and Borders General Hospital in Melrose.
Invited guests were involved in a special event on Wednesday (21st August) showcasing the live flight trial with presentations around the work conducted by Project CAELUS.
Currently, laboratory samples which inform urgent clinical decision-making are transported by road and can take up to five hours between NHS Borders and NHS Lothian due to due to needing to make multiple pick-ups.
Innovation activity being conducted by Project CAELUS could see this delivery take 35 minutes, enhancing the transport provision, particularly for rural areas.
Project CALEUS is working with 16 consortium partners to deliver what will be the first national drone network that can transport essential medicines, bloods and other medical supplies throughout Scotland including to remote communities.
Fiona Smith, Project Director for Project CAELUS said: “Our consortium has been working extremely hard to get to this stage and we are delighted we have been able to test this important use case for the NHS.
“Transporting laboratory specimens by drone could speed up the clinical decision making allowing for same day diagnosis and treatment.
“It is also one of the first times in the UK that there has been a demonstration of beyond the visual line of sight medical drone operations transiting between controlled and uncontrolled airspace.
“This is an important milestone for our project and we now look forward to testing more potential use cases by drone across Scotland in the coming months.”
Hazel Dempsey is the CAELUS NHS Scotland programme lead: “Our aim, from an NHS perspective, is to explore opportunities where drone technology could benefit patients and NHS services in urban, remote, rural and island landscapes.
“The NHS is reliant on van logistics that have provided valuable service for decades, however these can take time, travelling hundreds of road miles each day. In some parts of Scotland, patients who live in remote and rural locations are dependent on ferry or airline availability.
“This project will enable the NHS to consider if drone technology is viable and able to contribute to improving the health and wellbeing of our population. This project will position the United Kingdom and NHS Scotland as a leader in healthcare and aviation industries.”
CAELUS (Care & Equity – Healthcare Logistics UAS Scotland), is part funded by the UK Research and Innovation (UKRI) Future Flight Challenge.
It brings together 16 partners including the University of Strathclyde, Skyports Drone Services, NATS and NHS Scotland.
In the latest live flight trials, tests were also carried out on how NHS staff in future would engage with the drone both physically and digitally.
Dr Tracey Gillies, Medical Director and Executive Lead for Innovation, NHS Lothian said, “Across NHS Lothian, we are continually exploring ways to innovate and enhance our patient experience.
“Lothian and the surrounding areas are very diverse, from city to country and coastal living. Drones could play an important role in helping to transport samples for testing or speed up the delivery of critical medical supplies.
“These exciting trial flights have been a collaborative effort between our clinical leads, South East Innovation Hub and partner organisations and I look forward to seeing further developments with this project.”
Laura Jones, Director of Quality & Improvement at NHS Borders said: “We are proud to be involved in Project Caelus, exploring how drone technology could provide an additional logistics service to enhance access to essential medical supplies particularly in rural parts of Scotland like the Scottish Borders.
“Our involvement in this project is part of our commitment to providing high quality person-centred care by modernising services so that they are fit for the future using the technologies that are available to us going forward.”
Since January 2020, the CAELUS consortium has designed drone landing stations for NHS sites across Scotland and developed a virtual model (digital twin) of the proposed delivery network which connects hospitals, pathology laboratories, distribution centres and GP surgeries across Scotland.
In October 2023, in a hugely successful trial, flying took place between Glasgow Airport and NHS Golden Jubilee in Clydebank. This initiative was showcasing the integration of drones with modern airspace.
Live flight trials were operated by CAELUS consortium member Skyports Drone Services. The UK-based operator is an experienced provider of drone delivery, survey and monitoring services. The company has a long history of operating medical drone deliveries, including the first drone deliveries with the NHS.
The Scottish Ambulance Service also carried out a simulation study in August to better understand the feasibility of delivering an Automated External Defibrillators (AEDs) via drone technology.
Paul Gowens, Associate Director, Research and Innovation with the Scottish Ambulance Service, said: “We are delighted to be a key partner in Project CAELUS.
“Our recent study carried out in Edinburgh was a great success as we learned more about the feasibility of delivering an Automated External Defibrillators (AEDs) via drone technology. We look forward to working alongside AGS and our partners on Project CAELUS on future milestones.”
Richard Ellis, NATS New Airspace Users Director, said: “This is a major step forward for the project and its fantastic to see many of the operational concepts we’ve helped developed be put into use.
“We are now a step closer to realising a truly integrated airspace where drones fly safely and seamlessly alongside conventional aircraft.”
The University of Strathclyde’s principal investigator for the project, Dr Marco Fossati, said: “The latest live flight trials mark an important milestone in the journey to developing a national medical transport drone network.”
Mike McNicholas, managing director for Infrastructure at AtkinsRéalis said: “It is a fantastic step forward for the project to make its first drone delivery and to see the ground infrastructure in use as part of the test flight.
AtkinsRéalis has been working closely with the AGS Airports-led consortium on the development of large, portable landing pads that can be folded up and stored when not in use, or moved to another location to receive another drone landing.
“Using a combination of digital twin technology and live test flights, Project CAELUS is able to trial various prototypes, taking learnings from each iteration to hone designs and land on something that can demonstrate the viability, scalability and efficiency of a drone network for medical deliveries across Scotland.”
Anne-Lisa Scaillierez, partner at The Drone Office: “Public feedback from our engagement activities has shown overwhelming support for using drones in medical logistics across Scotland.
“We’re thrilled by the significant progress achieved as part of Project CAELUS.”
David Hiller, Associate Director of Arup, said: “Arup has been enormously privileged to contribute to such a pivotal study, helping to better understand the human impacts of noise in relation to health and wellbeing.
“The study facilitated by CAELUS is one of the first of its kind and will support broader innovation globally. Cross-sector collaboration is both exciting and crucial as the capabilities of advanced air mobility technology evolve.”
Connected Places Catapult’s Ecosystem Director for Air Mobility & Airports, Andrew Chadwick said: “It is tremendous to see drones being used as part of Project CAELUS to transport essential medical supplies from one site to another, particularly as this is the first time a drone flight has operated in Scotland between two different NHS health boards.
“Connected Places Catapult has been working with NHS Scotland to develop the business and economic cases for these types of services alongside consortium members, and we look forward to exploring future opportunities for drone operations.”
New partnership for pioneering kidney health research
Clinical trials to accelerate research into treating chronic kidney disease will be strengthened as a result of a new partnership between the Scottish Government, academia and industry.
NHS Scotland, AstraZeneca and the Universities of Dundee and Glasgow will work together on new medicines to slow the progression of chronic kidney disease, reducing the risk that patients might need dialysis or kidney transplantation.
The partnership will allow for development of new treatments to treat chronic kidney disease, build infrastructure and enhance expertise in renal clinical trial delivery in Scotland with the key aim of improving patient outcomes.
Preventing progression of the disease allows people to live longer, better lives, free from other consequences of the condition such as heart failure, cardiovascular disease and stroke. This allows people to work, contribute to their communities and economy, while reducing pressure on the NHS.
Cabinet Secretary for Health and Social Care, Neil Gray, said: “This project’s ‘triple helix’ approach is a shining example of how collaboration between the NHS, Scottish Government, academia and industry can accelerate health studies. As we navigate the complex issue of chronic kidney disease, our commitment to patient-centred research remains unwavering.
“Together we can advance targeted studies into medicines that slow progression of the disease and reduce the need for dialysis or transplantation, strengthen our workforce through dedicated research fellows and specialised training, provide greater opportunities for patients, and enable Scotland to attract and deliver more innovative trials.”
Professor Dame Anna Dominiczak, Chief Scientist (Health) at Scottish Government said: “I welcome this partnership with AstraZeneca which builds upon the excellent research infrastructure and expertise we have in Scotland, to drive the development of new treatments for chronic kidney disease.
“We must all work together to improve the outcomes and life circumstances for people living with kidney disease; and this partnership enables the fusion of medical expertise, knowledge, and insight from across NHS, academia, and industry.”
Tom Keith-Roach, AstraZeneca UK President, said: “Scotland is setting a bold ambition to change the trajectory of chronic kidney disease. We are thrilled to invest in a partnership with the University of Glasgow, the University of Dundee, and the Scottish Government to speed up the study of three potential new combination medicines to treat this disease.
“The triple helix of industry, academia and NHS Scotland is a powerful force with the potential to transform care and outcomes for people.
“Furthermore, we believe Scotland is well placed to collaborate with AstraZeneca to shape our research on the world stage across a number of disease areas and attract investment to the country’s thriving Life Science sector.”
A multi-disciplinary team established to consider how the recommendations in the Cass Review might apply to NHS services in Scotland has submitted its findings to the Scottish Parliament.
A senior clinical team, commissioned by the Chief Medical Officer for Scotland, considered all 32 recommendations of the Cass Review into Gender Identity Services for Children and Young People in NHS England.
The team assessed to what extent they were applicable in the Scottish context, and whether they could be implemented in Scotland’s health service.
Recommendations of the multi-disciplinary team included:
a lead senior clinician, preferably a consultant, should take overall responsibility for each young person’s care
each care plan should include a full assessment of the child’s needs, both psychological and physical
as elsewhere in the UK, the use of puberty-supressing hormones – commonly referred to as puberty blockers – should be paused until further clinical trials can be undertaken. NHS Scotland will continue to engage in the forthcoming UK study
work to design a regional service for children and young people should begin immediately, and services should ultimately be provided as locally as possible, based in children’s health services, with strong links between secondary and specialist services.
The conclusions of the report will now be considered by the Scottish Government – both in relation to how current services should be delivered to ensure service continuity, as well as on how these services should be commissioned in the future to ensure sustainable person-centred care.
Deputy Chief Medical Officer Professor Graham Ellis said: “The Cass Review was established to make recommendations on how to improve NHS England gender identity services for children and young people. Through this review we have aimed to set out which recommendations could apply to Scotland, and how they might be implemented.
“At the heart of this question are children and young people in distress, and our ambition must remain focused on meeting their needs with holistic, person-centred care as close to home as practical.
“The Cass Review identified the need to ensure that gender identity services for young people are more closely aligned with other areas of clinical practice, and that responsibility for the full range of services required should extend beyond specialist services. This will be essential as we seek to always provide the best possible care.
“In responding to the Cass Review, the multi-disciplinary team looked at the recommendations from a clinical perspective, always remembering that we have a responsibility to make sure that all children and young people grow up safe, respected and supported.”
Health Secretary Neil Gray said: “The Scottish Government welcomes the multi-disciplinary team’s report, which has carefully considered the Cass Review’s recommendations and how they apply to Scotland.
“The conclusions of the report will now be considered and used to improve gender identity healthcare for children and young people. The Scottish Government will update Parliament after summer recess.
“We remain absolutely committed, not just to ensuring ongoing support is available, but to reforming and improving gender identity healthcare across Scotland.”
